Evaluation of the assumptions of an ontogeny model of rat hepatic cytochrome p450 activity

被引:20
作者
Alcorn, Jane
Elbarbry, Fawzy A.
Allouh, Mohammed Z.
McNamara, Patrick J.
机构
[1] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK S7N 5C9, Canada
[2] Jordan Univ Sci & Technol, Dept Anat, Irbid, Jordan
[3] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA
关键词
D O I
10.1124/dmd.107.017590
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We previously reported an ontogeny model of hepatic cytochrome P450 (P450) activity that predicts in vivo P450 elimination from in vitro intrinsic clearance. The purpose of this study was to conduct investigations into key assumptions of the P450 ontogeny model using the developing rat model system. We used two developmentally dissimilar enzymes, CYP2E1 and CYP1A2, and male rats (n = 4) at age groups representing critical developmental stages. Total body and liver weights and hepatic microsomal protein contents were measured. Following high-performance liquid chromatography analysis, apparent K-M and V-max estimates were calculated using nonlinear regression analysis for CYP2E1- and CYP1A2-mediated chlorzoxazone 6-hydroxylation and methoxyresorufin O-dealkylation, and V-max estimates for p-nitrophenol and phenacetin hydroxylations, respectively. Hepatic scaling factors and V-max values provided estimates for infant scaling factors (ISF). The data show microsomal protein contents increased with postnatal age and reached adult values after postnatal day (PD) 7. Apparent K-M values were similar at all developmental stages except at <= PD7. Developmental increases in probe substrate V-max values did not correlate with the biphasic increase in immunoquantifiable P450. The activity of two different probe substrates for each P450 covaried as a function of age. A plot of observed ISF values as a function of age reflected the developmental pattern of rat hepatic P450. In summation, these observations diverge from several of the model's assumptions. Further investigations are required to explain these inconsistencies and to investigate whether the developing rat may provide a predictive paradigm for pediatric risk assessment for P450-mediated elimination processes.
引用
收藏
页码:2225 / 2231
页数:7
相关论文
共 38 条
[1]  
Alcorn J, 2002, CLIN PHARMACOKINET, V41, P1077, DOI 10.2165/00003088-200241130-00005
[2]   Ontogeny of hepatic and renal systemic clearance pathways in infants - Part I [J].
Alcorn, J ;
McNamara, PJ .
CLINICAL PHARMACOKINETICS, 2002, 41 (12) :959-998
[3]   Ontogeny of hepatic and plasma metabolism of deltamethrin in vitro: Role in age-dependent acute neurotoxicity [J].
Anand, SS ;
Kim, KB ;
Padilla, S ;
Muralidhara, S ;
Kim, HJ ;
Fisher, JW ;
Bruckner, JV .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (03) :389-397
[4]   Computational pharmacokinetics during developmental windows of susceptibility [J].
Barton, HA .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2005, 68 (11-12) :889-900
[5]  
Björkman S, 2006, CLIN PHARMACOKINET, V45, P1
[6]   EXPRESSION OF P450 ISOENZYMES DURING RAT-LIVER ORGANOGENESIS [J].
BORLAKOGLU, JT ;
SCOTT, A ;
HENDERSON, CJ ;
WOLF, CR .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1993, 25 (11) :1659-1668
[7]   Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages [J].
Brent, RL .
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2004, 71 (05) :303-320
[8]  
Carlile DJ, 1997, DRUG METAB DISPOS, V25, P903
[9]   Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment [J].
Clark, LH ;
Setzer, RW ;
Barton, HA .
RISK ANALYSIS, 2004, 24 (06) :1697-1717
[10]   REGULATION OF DRUG-METABOLIZING-ENZYMES DURING THE PERINATAL-PERIOD IN RAT AND HUMAN-LIVER [J].
CRESTEIL, T .
BIOESSAYS, 1987, 7 (03) :120-124